If this short is real, and I’m still struggling to understand why they picked nzuri. Last hours trading shows the conundrum they face, $10k of buying put them underwater on a $500k borrow.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025